शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
ALKEMNSEAlkem Laboratories Limited· Pharmaceuticals & BiotechnologyHighNegative
Announced Wed, 24 Sept, 2025 · 14:26 IST

Alkem Laboratories Limited has informed the Exchange about Action(s) initiated or orders passed

ALKEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.0%Reaction day
₹5570.50
prior close
₹5579.50
announcement price
In-mkt
timing
Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)-0.9%+0.9% vs market
Pharmaceuticals peers, median of 154sector-0.5%+0.5% vs sector

On the reaction day the stock moved 0.9 pts more than Nifty Midcap 150 and 0.5 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.0
10m
+0.0
15m
+0.0
30m
-0.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.0-0.9+0.9-0.5+0.5
Next day
-0.8-1.5+0.8-1.4+0.6
2d
-2.8-3.4+0.6-3.4+0.6
3d
-2.0-3.2+1.2-3.8+1.8
4d
-2.6-3.1+0.5-3.7+1.1
5d
-1.8-2.3+0.4-2.6+0.7
1w
-1.3-0.7-0.5-2.8+1.5
15d
-0.5+0.9-1.4-3.8+3.3
1m
-0.5+0.8-1.3-3.8+3.3
2m
+0.6+1.7-1.0-7.1+7.8
3m
-0.3+2.5-2.8-7.7+7.4
UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 154Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Alkem Laboratories has received an appeal order from the GST Appellate Authority in Panchkula, Haryana, for the period July 2017–2018 to 2020–2021. The order has confirmed a GST demand of about Rs. 23.4 lakhs along with an equal amount as interest and penalty, taking the total potential outflow to roughly Rs. 46.8 lakhs plus interest. The dispute relates to the alleged non-reversal of common Input Tax Credit (ITC) attributable to exempt supplies. The company has stated it does not agree with the order and is in the process of filing a further appeal. Alkem has clarified there is no material impact on its financial or operational activities from this order.

Likely market impact

The demand is small relative to Alkem's size, and the company is contesting it, so the financial hit is likely limited. Shareholders are unlikely to see a meaningful stock reaction unless the matter escalates materially in future rounds of litigation.